The overexpression of SIGIRR in RCC cells attenuated IL1-induced NFKBIZ activation, with a trend of effect on IL6, PD-L1, and ICAM1 induction, suggesting that SIGIRR manipulation may be beneficial to block IL1 in kidney cancer. The gene discussed is IL1B; the disease is renal cell carcinoma.